mTOR signaling in tumorigenesis.

Area of Science:

• Molecular Biology
• Oncology
• Cellular Signaling

Background:

• The mechanistic target of rapamycin (mTOR) is a key kinase regulating cellular growth, proliferation, and survival.
• Dysregulation of the mTOR signaling pathway is a common hallmark of human cancers, driving tumor progression.
• Targeting oncogenic mTOR pathway components presents a promising anti-cancer strategy.

Purpose of the Study:

• To review genetic mouse models for mTORC1 and mTORC2 components.
• To summarize upstream regulators and downstream targets of mTOR.
• To assign potential oncogenic or tumor suppressive roles to evaluated mTOR pathway molecules.

Main Methods:

• Literature review of genetic mouse models for mTORC1 and mTORC2.
• Analysis of characterized mTOR upstream regulators and downstream targets.
• Evaluation of the oncogenic or tumor suppressive roles of mTOR pathway components.

Main Results:

• Compilation of genetic mouse models for key mTOR pathway components.
• Identification of upstream regulators and downstream targets influencing mTOR signaling.
• Assignment of specific oncogenic or tumor suppressive roles to various mTOR molecules.

Conclusions:

• Enhanced understanding of mTOR biology and its role in cancer.
• Provides a molecular basis for developing targeted therapies against mTOR pathway in cancer.
• Facilitates future research directions in mTOR signaling and cancer therapeutics.